183 related articles for article (PubMed ID: 30077474)
21. Deterioration of diabetic nephropathy via stimulating secretion of cytokines by atrial natriuretic peptide.
Liu C; Li Q; Feng X; Zhu J; Li Q
BMC Endocr Disord; 2021 Oct; 21(1):204. PubMed ID: 34663293
[TBL] [Abstract][Full Text] [Related]
22. Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial.
Omidian M; Mahmoudi M; Javanbakht MH; Eshraghian MR; Abshirini M; Daneshzad E; Hasani H; Alvandi E; Djalali M
Diabetes Metab Syndr; 2019; 13(5):2873-2877. PubMed ID: 31425951
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
Fawzy MS; Abu AlSel BT
J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609
[TBL] [Abstract][Full Text] [Related]
24. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy.
Akhbari M; Khalili M; Shahrabi-Farahani M; Biglari A; Bandarian F
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414764
[TBL] [Abstract][Full Text] [Related]
25. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
26. Increased levels of circulating (TNF-α) is associated with (-308G/A) promoter polymorphism of TNF-α gene in Diabetic Nephropathy.
Umapathy D; Krishnamoorthy E; Mariappanadar V; Viswanathan V; Ramkumar KM
Int J Biol Macromol; 2018 Feb; 107(Pt B):2113-2121. PubMed ID: 29042282
[TBL] [Abstract][Full Text] [Related]
27. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
Thipsawat S
Diab Vasc Dis Res; 2021; 18(6):14791641211058856. PubMed ID: 34791910
[TBL] [Abstract][Full Text] [Related]
28. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
29. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
30. Interplay between long non-coding RNA MALAT1 and pyroptosis in diabetic nephropathy patients.
Shoeib HM; Keshk WA; Al-Ghazaly GM; Wagih AA; El-Dardiry SA
Gene; 2023 Jan; 851():146978. PubMed ID: 36270460
[TBL] [Abstract][Full Text] [Related]
31. YKL-40 in type 2 diabetic patients with different levels of albuminuria.
Brix JM; Höllerl F; Koppensteiner R; Schernthaner G; Schernthaner GH
Eur J Clin Invest; 2011 Jun; 41(6):589-96. PubMed ID: 21158852
[TBL] [Abstract][Full Text] [Related]
32. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
33. Significance of glycated LDL in different stages of diabetic nephropathy.
Siddiqui K; George TP; Nawaz SS; Yaslam M; Almogbel E; Al-Rubeaan K
Diabetes Metab Syndr; 2019; 13(1):548-552. PubMed ID: 30641763
[TBL] [Abstract][Full Text] [Related]
34. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
35. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy.
Al-Kafaji G; Al-Muhtaresh HA
Mol Med Rep; 2018 Jul; 18(1):1171-1180. PubMed ID: 29845236
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.
Elkholy RA; Younis RL; Allam AA; Hagag RY; Abdel Ghafar MT
J Investig Med; 2021 Aug; 69(6):1189-1195. PubMed ID: 33863755
[TBL] [Abstract][Full Text] [Related]
37. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
38. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
40. Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry.
Nilavan E; Sundar S; Shenbagamoorthy M; Narayanan H; Nandagopal B; Srinivasan R
Diabetes Metab Syndr; 2020; 14(6):2073-2078. PubMed ID: 33125920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
